Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neiyifang (Changhai Hospital)
- Development stage
- Unknown
- Lead developer
- Changhai Hospital
- Administration
- Oral
01
Overview
Neiyifang is a Traditional Chinese Medicine (TCM) herbal formula developed by Shanghai Changhai Hospital for the treatment of endometriosis. It is specifically designed to treat the TCM syndrome of "cold coagulation and blood stasis," which is clinically associated with symptoms such as chronic pelvic pain and dysmenorrhea. The formula is typically administered as a granule and is intended to warm the meridians, promote blood circulation, and resolve stasis to alleviate the growth and symptoms of ectopic endometrial tissue. It is currently being evaluated in multicenter, randomized, double-blind clinical trials to establish its efficacy and safety profile compared to standard treatments or placebo.
- Other names
- Neiyi prescriptionNeiyi formulaNeiyi formula granule
Beyond the preview
Go deeper on Neiyifang (Changhai Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neiyifang (Changhai Hospital).